Search filters

List of works by Parameswaran Venugopal

A case of lenalidomide-dependent myelodysplastic syndrome

scientific article published on 30 June 2017

A novel method for single cell detection of in situ telomerase or histone H3 in combination with clonal analysis by FISH

scientific article published on 01 June 2003

Aggressive disease defined by cytogenetics is associated with cytokine dysregulation in CLL/SLL patients

scientific article

All in the family: Clueing into the link between metabolic syndrome and hematologic malignancies.

scientific article published on 28 September 2014

Alterations in IRF1/IRF2 expression in acute myelogenous leukemia

scientific article published on 01 September 2001

Arsenic trioxide and thalidomide combination produces multi-lineage hematological responses in myelodysplastic syndromes patients, particularly in those with high pre-therapy EVI1 expression.

scientific article

Biologic characteristics of patients with hypocellular myelodysplastic syndromes

scientific article published on 01 April 1999

Bone Marrow and Peripheral Blood AML Cells Are Highly Sensitive to CNDAC, the Active Form of Sapacitabine

scientific article

Clofarabine: a new treatment option for patients with acute myeloid leukemia.

scientific article

Correlation of tumor necrosis factor alpha (TNF alpha) with high Caspase 3-like activity in myelodysplastic syndromes

scientific article published on June 1999

Cytokine gene activity in AML cells in vivo in patients

scientific article published in May 1998

Cytokine production by in vitro processed and unprocessed haematopoietic cells

scientific article published on 01 July 2000

Cytokines, molecular biological abnormalities, and acute myelogenous leukemia

scientific article published on April 1997

Effects of cytokines on CD20 antigen expression on tumor cells from patients with chronic lymphocytic leukemia

scientific article published on 01 May 2000

Efficacy and safety of clofarabine in relapsed and/or refractory non-Hodgkin lymphoma, including rituximab-refractory patients

scientific article

Efficacy and safety of rituximab combined with ESHAP chemotherapy for the treatment of relapsed/refractory aggressive B-cell non-Hodgkin lymphoma

scientific article

Evidence for involvement of tumor necrosis factor-alpha in apoptotic death of bone marrow cells in myelodysplastic syndromes

scientific article published on 01 January 1999

GM-CSF plus rituximab immunotherapy: translation of biologic mechanisms into therapy for indolent B-cell lymphomas.

scientific article published on September 2008

Granulocyte-macrophage colony stimulating factor-induced immune priming of cyclophosphamide, doxorubicin, vincristine, and prednisone with rituximab chemoimmunotherapy in previously untreated patients with diffuse large B-cell lymphoma and mantle ce

scientific article published on 24 June 2011

Impact of insulin-like growth factor 1 and insulin-like growth factor binding proteins on outcomes in acute myeloid leukemia

scientific article published on 14 May 2015

Involvement of cyclin D1 and E2F1 in intramedullary apoptosis in myelodysplastic syndromes.

scientific article published in August 2003

Measurement of apoptosis, proliferation and three cytokines in 46 patients with myelodysplastic syndromes.

scientific article published on November 1996

Oral sapacitabine for the treatment of acute myeloid leukaemia in elderly patients: a randomised phase 2 study

scientific article

P15INK4B gene methylation and expression in normal, myelodysplastic, and acute myelogenous leukemia cells and in the marrow cells of cured lymphoma patients

scientific article published on 01 October 2001

Phase III open-label randomized study of cytarabine in combination with amonafide L-malate or daunorubicin as induction therapy for patients with secondary acute myeloid leukemia

scientific article published on 2 March 2015

Poor prognosis acute myelogenous leukemia 2--biological and molecular biological characteristics and treatment outcome

scientific article published on 01 September 2000

Poor prognosis acute myelogenous leukemia: 1 – response to treatment with high dose cytarabine/mitoxantrone/ethyol @ (Amifostine)

article

Poor prognosis acute myelogenous leukemia: 3--biological and molecular biological changes during remission induction therapy

scientific article published in September 2001

Presence of activation-related m-RNA for EBV and CMV in the bone marrow of patients with myelodysplastic syndromes

scientific article published on 01 March 2001

Remicade as TNF suppressor in patients with myelodysplastic syndromes.

scientific article

SCF, IL-1beta, IL-1ra and GM-CSF in the bone marrow and serum of normal individuals and of AML and CML patients

scientific article published on 01 June 2000

Safety and efficacy of combination therapy with fludarabine, mitoxantrone, and rituximab followed by yttrium-90 ibritumomab tiuxetan and maintenance rituximab as front-line therapy for patients with follicular or marginal zone lymphoma

scientific article published on 22 June 2011

Signal antonymy unique to myelodysplastic marrows correlates with altered expression of E2F1

scientific article published on 01 May 2000

Thalidomide produces transfusion independence in long-standing refractory anemias of patients with myelodysplastic syndromes.

scientific article published in August 2001

The clinical and biological effects of thalidomide in patients with myelodysplastic syndromes.

scientific article published in December 2001

The evolving role of alemtuzumab in management of patients with CLL.

scientific article

Tumor necrosis factor modulates CD 20 expression on cells from chronic lymphocytic leukemia: a new role for TNF alpha?

scientific article published on 01 August 2000

Paulina is supported by:

About Paulina

Help